Drug
Metronidazole Hydrochloride
Metronidazole Hydrochloride is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
67%
Ph early_phase_1
1
33%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 2Efficacy & side effects
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (33.3%)
Phase 22 (66.7%)
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_2
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
NCT00002682
unknownearly_phase_1
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
NCT03042091
completedphase_2
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
NCT00003151
Clinical Trials (3)
Showing 3 of 3 trials
NCT00002682Phase 2
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
NCT03042091Early Phase 1
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
NCT00003151Phase 2
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3